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Research utility of noninvasive methods 
for measurement of cardiac output 
Two noninvasive methods of cardiac index (Q) determination, pulsed Doppler echocardiography (Q), 
and CO2 rebreathing (Q,02) were compared to dye dilution in eight normal volunteers. Measurements 
of Q were made by dye dilution (Q,,,,) and the two noninvasive techniques under the following conditions: 
(1) supine rest, (2) after inflation of cuffs around the thighs, (3) 35-degree head-up tilt, (4) supine rest 
repeated, (5) during constant isoproterenol infusion, and (6) after an intravenous bolus of propranolol. 
When mean Q values of the group for each intervention were compared, close agreement was observed 
between dye dilution and each noninvasive method (Q_Dor = 1.08 QDD 0.07 L/min m2, r = 0.99, 
SEE = 0.02; Q02 = 0.68 Q,,,, + 0.84 L/min m2, r = 0.97, SEE = 0.02). Fair correlations were 
achieved when all 48 paired observations were analyzed (Q,, = 1.00 Q_,,, + 0.17 L/min ne, r = 0.89, 
SEE = 0.17; QCO2 = 0.71 Q., + 0.77 L/min m2, r = 0.79, SEE = 0.20). However, the Doppler 
ultrasound technique was significantly more precise in quantitating changes in Q in individual patients. 
These results demonstrate that estimates of Q can be made with reasonable accuracy by either CO2 
rebreathing or Doppler echocardiography. However, the Doppler technique is a much more accurate 
means of quantitating acute changes in Q. (CLIN PHARMACOL THER 1987;41:419-25.) 
Alan L. Hinderliter, M.D., M. Andrew Fitzpatrick, M.D., Nicholas Schork, B.S., 
and Stevo Julius, M.D., Sc.D. Ann Arbor, Mich. 
Much progress in our understanding of the physiology 
of the cardiovascular system and the pathophysiology 
of its disorders has stemmed from hemodynamic re- 
search in human subjects. The accurate determination 
of cardiac output (Q) has been essential for such studies. 
Until recently, however, the most reliable methods of 
Q measurement have required right heart catheterization 
and arterial cannulation. These invasive techniques are 
associated with some discomfort and morbidity and are 
not well suited for repeated measures over periods lon- 
ger than several hours. 
Recent technologic advances in Doppler echocar- 
diography have made possible accurate noninvasive es- 
timates of Q. A number of investigators have demon- 
strated that Q calculated from Doppler measurements 
of ascending aortic blood flow in resting patients cor- 
relates well with values obtained by thermodilution.' 
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Others have shown the usefulness of the Doppler tech- 
nique in estimating Q changes in response to vasodi- 
lators and inotropic agents." 
This study was undertaken to further evaluate the 
ability of Doppler ultrasonography to measure serial 
changes in Q in human laboratory subjects. In addition, 
we compared the accuracy of this technique to that of 
CO, rebreathing, a noninvasive means of Q measure- 
ment used previously in our laboratory. In contrast to 
the Fick and dye-dilution methods, in which Q is 
measured directly, Doppler ultrasonography measures 
stroke volume (SV); Q is then calculated as a function 
of heart rate (HR). Validation of the Doppler method 
then requires demonstration that it is capable of quan- 
titating changes in Q that are independent of HR alter- 
ations. For this reason our study was performed in sub- 
jects who underwent a series of maneuvers designed to 
produce a variety of Q and HR changes. Specifically, 
with isoproterenol we increased both Q and HR; with 
tilt we decreased Q but increased HR; with propranolol 
both Q and HR were decreased; and finally with thigh 
cuff inflation we decreased Q without altering HR. Af- 
ter each intervention, Q was measured by both non- 
invasive techniques and the results were compared to 
dye-dilution determinations. 
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Table I. HR and Q as measured by dye dilution, Doppler, and CO, rebreathing with each intervention 
Results are expressed as mean ± SE. 
METHODS 
Study group. The study group consisted of eight 
normal male volunteers ranging in age from 22 to 30 
years. All had normal physical examinations, and none 
had any history of pulmonary or cardiovascular disease. 
Each subject read and signed a detailed informed con- 
sent form. 
Protocol. The study protocol was approved by the 
Human Use Committee at the University of Michigan. 
After introduction to the laboratory, subjects were 
placed supine on a tilt table and catheters were inserted. 
Pressure cuffs were applied loosely around the thighs 
and, when required, pressured by a rapid inflator 
(D. E. Hokanson, Inc., Issaquah, Wash.). 
Measurements of Q were then made by dye dilution, 
Doppler ultrasonography, and CO, rebreathing under 
the following conditions: control 1: 15 minutes after 
insertion of catheters; cuff: 10 minutes after inflation 
of thigh cuffs to 60 mm Hg; tilt: 10 minutes after de- 
flation of thigh cuffs and after assuming a 35-degree 
head-up tilt position; control 2: 10 minutes after re- 
turning to supine position; isoproterenol: during a con- 
stant intravenous infusion of isoproterenol titrated to 
produce an increase in HR of about 10 bpm (10 to 15 
mEq/kg/min in most cases); and propranolol: 30 min- 
utes after administration of 0.2 mg/kg propranolol in- 
travenously. 
Doppler and rebreathing recordings were made by a 
single operator who was unaware of the dye-dilution 
results. Similarly, one investigator performed all of the 
dye-dilution measurements using a standard technique. 
Each dye dilution, Doppler, and rebreathing tracing was 
assigned a random number and interpreted blindly. All 
measurements were made in triplicate by each of the 
three methods and mean values were calculated. 
Doppler measurements. A range-gated, pulsed 
Doppler system (ATL MK600 Adaptive Doppler Ul- 
trasound; Advanced Technology Laboratories, Inc., 
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Belleville, Wash.) was used to measure Q. Measure- 
ments of blood flow velocity in the ascending aorta 
were made with a small 3 MHz transducer positioned 
in the suprasternal notch. With the exception of small 
adjustments made during head-up tilt, the same sam- 
pling depth was used for each set of observations in an 
individual subject. Analysis of returning Doppler sig- 
nals was performed by the instrument every 10 msec 
by fast Fourier transform, and the data were plotted 
with time along the x axis, frequency shift along the 
y axis, and the prevalence of frequency components in 
shades of gray. With the assumption that blood flow 
was parallel to the ultrasound beam, instantaneous ve- 
locity was calculated from the Doppler equation: 
V = cfd/2f3, where c =- the speed of sound in tissue 
(1540 cm/sec), fd Doppler frequency shift, and 
fd = transmitted ultrasound frequency (3 MHz). 
Spectral images were recorded on dry silver paper 
and were analyzed by a method similar to that described 
by Elkayam et al.' The flow-velocity integral (FVI), 
or the area under a flow-velocity curve, was estimated 
by the equation FVI = 0.57 (PFV) (ET) +0.9 cm. 
This relation was derived by regression analysis of 
planimetered areas as a function of the products of PFV 
and ET in a separate series of curves (r = 0.98). The 
average FYI of five consecutive beats was calculated 
for each tracing. 
The cross-sectional area (CSA) of the aorta was 
calculated from the diameter (D) as CSA = 7rD2/4. 
The diameter was measured from a standard 2-D long- 
axis parasternal view at a point just distal to the si- 
nus of Valsalva. Images were frozen during systole 
(on the peak of the T wave), and measurements were 
made with electronic calipers using an inner-to-inner 
wall convention. The CSA used in calculating Q values 
for each patient was the arithmetic mean of three sep- 
arate determinations. It was assumed that the dimen- 
sions of the ascending aorta remained constant through- 
Intervention 
HR 
(bPm) 
Dye dilution 
(Llmin m2) 
Doppler 
(L/min m2) 
CO, rebreathing 
(Llmin m2) 
Control 1 57.7 ± 1.7 3.04 ± 0.40 3.30 ± 0.56 2.81 ± 0.64 
Cuff 58.3 ± 2.1 2.68 ± 0.32 2.87 ± 0.45 2.52 ± 0.36 
Tilt 73.8 ± 1.6 2.45 ± 0.34 2.35 ± 0.33 2.74 ± 0.52 
Control 2 55.0 ± 1.6 2.93 ± 0.45 3.08 ± 0.47 2.74 ± 0.54 
Isoproterenol 64.9 ± 1.4 4.52 ± 0.65 4.75 ± 0.80 3.95 ± 0.81 
Propranolol 50.9 -± 2.2 2.49 -± 0.38 2.69 ± 0.37 2.51 ± 0.50 
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Table II. Correlation coefficients for each 
patient relating Q values measured by dye 
dilution to values measured by Doppler and 
CO, rebreathing 
out the study (i.e., that they were not changed by 
the interventions used to alter hemodynamics). 
HR was determined from a simultaneously recorded 
ECG. 
Q was calculated as the product of FVI, CSA, and 
HR divided by body surface area (BSA). 
CO, rebreathing measurements. Q measured by the 
rebreathing technique was calculated from the follow- 
ing equation: 
Q = (Vc0,/[cc0, _ .02])/BSA 
where Q = cardiac output in liters per minute, Vco2 
CO, production in milliliters per minute STP, C V,2 = 
CO, content of mixed venous blood in milliliters per 
liter, and Cac02 = CO, content of arterial blood in mil- 
liliters per liter. 
Instantaneous determinations of Pco, were made 
with a Hewlett-Packard Model 47210A Capnometer 
(Hewlett-Packard Co., Medical Products, Waltham, 
Mass.) connected in series with the mouthpiece of the 
rebreathing apparatus. 
Vc02 was calculated as the product of minute venti- 
lation, determined by a timed collection, and the mean 
concentration of CO, in expired gas. 
C Vc02 was measured indirectly by the equilibration 
rebreathing method initially described by Collier et al.' 
Cac02 was derived from the Pco, measured at end- 
tidal expiration. 
A standard CO, dissociation curve for oxygenated 
blood was used to convert partial pressures to CO2 
content.' 
Studies were considered acceptable if end-tidal Pc02 
varied by 1 mm Hg on the three breaths preceding the 
rebreathing procedure and if a "plateau" was achieved 
within 15 seconds from the start of rebreathing. 
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Fig. 1. Relationship between mean Q values during each 
intervention as measured by dye dilution and (A) Doppler or 
(B) CO, rebreathing. The dashed line represents the line of 
identity. 
Dye-dilution measurements. Dye-dilution measure- 
ments of cardiac output were made by a technique that 
has been described previously in detail." In brief, a 
polyethylene PE-50 catheter (Clay Adams, Division of 
Becton Dickinson and Co., Parsippany, N.J.) was in- 
troduced percutaneously into an antecubital vein and 
advanced into the right atrium form delivery of indicator 
dye (Cardio-Green; Hynson, Westcott and Dunning, 
Inc., Baltimore, Md.). A 2-inch 18-gauge plastic can- 
nula was inserted into the left brachial artery to allow 
continuous withdrawal of blood through an Electronics 
for Medicine densitometer (Honeywell Corporation, 
Van Nuys, Calif.). Cardiac output curves and lead II 
3 4 
dye dilution (1/min M2) 
2 3 4 5 
dye dilution (1/min M2) 
Fig. 2. Relationship between each Q value measured by dye 
dilution and (A) Doppler or (B) CO2 rebreathing. The least- 
squares regression line (solid) and line of identity (dashed) 
are shown. 
of the ECG were recorded on the thermal recorder. Dye 
curves were calibrated by the addition of known quan- 
tities of dye to aliquots of blood that were drawn through 
the densitometer. 
Data analysis. Regression and correlation analyses 
were used to compare Q values obtained from the non- 
invasive Doppler and rebreathing methods, with Q val- 
ues obtained from the dye-dilution method for both 
individual and group measurements. Sample size esti- 
mates were calculated by solving (for what amounts to 
the smallest) N given the difference between the means 
and SDs of these differences and setting the a and 
errors at a specified level (a = 0.05; 3 = 0.2).12 
RESULTS 
Technically satisfactory rebreathing studies and 
Doppler flow tracings were obtained in all eight pa- 
tients. Table I lists the mean HR and Q values obtained 
by the three methods under each condition. Strong cor- 
relations were obtained between dye-dilution and both 
the Doppler (r = 0.99) and CO, rebreathing (r =- 
0.97) methods, as illustrated in Fig. 1. The slightly 
weaker correlation with rebreathing was the result of 
significant overestimates of Q by this technique during 
head-up tilt; when the tilt values were not considered, 
r = 0.99. Doppler values were, on average, slightly 
greater than those determined by dye dilution. In con- 
trast, Q was somewhat underestimated in the supine 
position by the rebreathing method. 
Fig. 2 is a graph of all 48 observations in the eight 
patients, plotting dye-dilution Q values against (A) 
Doppler and (B) rebreathing estimates. Dye-dilution 
and Doppler measurements were related to the follow- 
ing equation: QD, = 1.00 QDD + 0.71 L/min m2. 
Although a close correlation was observed (r = 
0.89), substantial differences were noted in some in- 
dividual measurements, as reflected by the SEE of 
0.17 L/min m2. Similar analysis of paired dye-di- 
lution and rebreathing Q determinations resulted in 
the following relationship: Qc02 = 0.71 QDD ± 0.77 
L/min m2. The correlation with dye dilution was 
weaker (r = 0.79) and the scatter was greater (SEE = 
0.20 L/min m2) with this technique than with the 
Doppler method. 
As illustrated in Table II, there was a close correla- 
tion between Doppler and dye-dilution values in every 
subject; r was 0.96 or greater in six of the eight patients 
and averaged 0.96. Correlation coefficients with re- 
breathing ranged from 0.80 to 0.97 and averaged 
0.89. 
To assess the utility of Doppler echocardiography and 
CO, rebreathing in clinical research, we calculated the 
sample sizes required for these methods to detect the 
changes produced by each intervention. These results 
are displayed in Table III. In every case, for both the 
dye-dilution and Doppler methods, sample sizes of six 
or less were sufficient to establish a change in mean Q 
with 95% confidence. However, only the relatively 
large increase resulting from isoproterenol infusion 
could have been established with such a small group 
using CO, rebreathing. Rebreathing measurements dur- 
ing tilt were unreliable, and large sample sizes would 
have been required to demonstrate a change in response 
to cuff inflation or 13-blockade. 
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Table III. Mean Q changes in response to cuff inflation, tilt, isoproterenol, and propranolol as measured by 
each method, with calculated sample sizes needed to detect changes at the 5% level 
Estimated sample sizes are based on each technique's mean change and SD, with n set at 0.05 and r3 set at 0.2. 
*P < 0.005. 
DISCUSSION 
Q can be measured accurately by invasive techniques 
such as indicator dilution or thermodilution. Since these 
methods are associated with some discomfort and mor- 
bidity, however, their usefulness in experimental med- 
icine has been limited to laboratory studies in relatively 
small numbers of patients. In view of the importance 
of Q assessment in studies of human physiology and 
clinical pharmacology, a reliable noninvasive method 
of measuring this parameter would be a valuable in- 
vestigational tool. 
This study was designed to compare the accuracy of 
CO, rebreathing and Doppler ultrasonography in as- 
sessing acute hemodynamic changes in human labo- 
ratory subjects. As illustrated in Table I, the physiologic 
and pharmacologic interventions we employed resulted 
in a wide range of hemodynamic alterations. Infusion 
of isoproterenol and propranolol resulted in changes in 
Q that paralleled those in HR, head-up tilt induced an 
increase in HR but a fall in Q, and thigh cuff inflation 
produced in a decrease in Q with a minimal alteration 
of HR. 
Our results demonstrate that close correlations be- 
tween indicator dilution and noninvasive measurements 
of Q can be attained. Comparison of dye-dilution and 
Doppler determinations for all 48 measurements re- 
sulted in a correlation coefficient of 0.89. These data 
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are comparable to the published results of other series 
measuring SV or Q from the suprasternal notch, in- 
cluding those by Huntsman et a13 (r = 0.94; n = 110 
in 45 patients), Rose et a18 (r = 0.92; n = 16), and 
Goldberg et al.2 (r = 0.91; n = 16). Results of pre- 
vious studies designed to assess the reliability of CO, 
rebreathing in measuring resting Q are variable. Many 
authors have reported close agreement with direct Fick 
or dye-dilution measurements during exercise but poor 
correlations at rest.'3' More recently, especially with 
the use of the Collier equilibration technique for the 
estimation of mixed venous Pco,, other investigators 
have obtained accurate results in resting, supine pa- 
tients."'" Our correlation coefficient of 0.79 was sim- 
ilar to results noted previously in our laboratory.' 
When mean Q values were calculated for each con- 
dition in our study, close agreement was observed be- 
tween dye dilution and both noninvasive techniques. 
However, rebreathing measurements made in the tilt 
position were considerably higher than expected, prob- 
ably because of alterations of the physiologic dead space 
and ventilation-perfusion relationships produced by 
postural changes 20.21 
In theory, Doppler ultrasonography should be partic- 
ularly well suited to evaluating changes in Q in indi- 
vidual patients. The measurement of aortic CSA is a 
source of significant error in the calculation of absolute 
Intervention 
Dye dilution 
(Llmin n12) 
Doppler 
(Li min tn2) 
CO, rebreathing 
(Li min m2) 
Cuff 
Mean Q change 0.36* 0.43* 0.18 
SD 0.22 0.21 0.42 
Sample size <5 <5 33-40 
Tilt 
Mean Q change 0.59* 0.95* 0.06 
SD 0.37 0.36 0.38 
Sample size <5 <5 >101 
Isoproterenol 
Mean Q change 1.59* 1.67* 1.21* 
SD 0.64 0.49 0.71 
Sample size <5 <5 <5 
Propranolol 
Mean Q change 0.45* 0.39* 0.22 
SD 0.29 0.22 0.42 
Sample size 5 <5 22-27 
424 Hinekrliter et al. 
values of SV or Q. Studies in humans indicate that this 
area is dependent on intra-aortic pressure and changes 
by 5% to 15% during the cardiac cycle.''' Moreover, 
small errors in measurement of the aortic diameter are 
compounded when this dimension is squared in the 
calculation of area. If one assumes that the dimensions 
of the aorta remain constant during the period of ob- 
servation, relative changes in Q can be assessed without 
consideration of the CSA. In our study group a strong 
correlation was found between dye dilution and Doppler 
determinations of Q in each of the eight subjects, with 
a mean r value of 0.96. The expected directional 
changes in Q were confirmed in every case. Thus even 
though errors in CSA measurement may have resulted 
in significant overestimation or underestimation of Q 
in some subjects, relative changes in Q were determined 
with great accuracy. 
The results with CO2 rebreathing were less satisfac- 
tory. Although relative changes in response to cuff in- 
flation, isoproterenol, and propranolol were accurately 
quantitated by this method for the group as a whole, 
significant error was often observed in individual mea- 
surements. 
The principal objective of this study was to assess 
the utility of different methods of Q measurement in 
clinical research. Since noninvasive techniques involve 
less risk and discomfort than dye dilution or Fick mea- 
surements, they generally meet with greater acceptance 
by human subjects. To be useful in experimental work, 
however, these methods must be capable of demon- 
strating, with statistical confidence, changes in Q in a 
small group of patients. In our experience, comparable 
sample sizes were required for the Doppler and dye- 
dilution methods to establish Q alterations in response 
to physiologic and pharmacologic maneuvers. With CO, 
rebreathing, however, larger groups were required to 
prove a change with three of the four interventions. 
Several features of our methodology and study pop- 
ulation affect the applicability of these results. Our mea- 
surements were performed in healthy, cooperative 
young men at rest, and factors influencing the ease of 
Doppler measurements in other subjects might ad- 
versely affect the precision of Q determinations. Dopp- 
ler estimates of aortic flow are technically difficult in 
moving patients, for example, and for this reason CO, 
rebreathing may be a more accurate method of assessing 
the response of Q to exercise. In addition, we cannot 
exclude the possibility that propranolol and isoproter- 
enol caused regional changes in the ventilation/perfu- 
sion ratio, resulting in rebreathing measurement errors 
that would not be seen with agents having no effect on 
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bronchiolar tone. However, it should be noted that re- 
breathing measurements of responses to propranolol 
and isoproterenol were no less accurate than those of 
changes produced by thigh cuff inflation. 
In summary, pulsed Doppler echocardiography and 
CO2 rebreathing are useful techniques for the nonin- 
vasive measurement of Q. However, calculation of ab- 
solute values for Q by the Doppler method necessitates 
accurate measurement of the aortic cross-sectional area. 
Since this potential source of error does not complicate 
comparisons of serial measurements of Q in individual 
subjects, the Doppler method is particularly well suited 
to measuring acute Q changes. CO, rebreathing can 
provide reasonably accurate estimates of resting Q in 
healthy subjects. In our laboratory, however, measure- 
ments of changes in Q in individual patients are less 
reliable. These findings suggest that both noninvasive 
methods may be useful in human hemodynamic studies, 
especially when applied to a group of subjects. How- 
ever, Doppler echocardiography is a much more ac- 
curate means of quantifying Q responses to pharma- 
cologic and physiologic maneuvers. 
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